These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9091843)

  • 1. [Sabal serrulata extract in the management of symptoms of prostatic hypertrophy].
    Kondás J; Philipp V; Diószeghy G
    Orv Hetil; 1997 Feb; 138(7):419-21. PubMed ID: 9091843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experience in treating benign prostatic hypertrophy with Sabal serrulata for one year.
    Romics I; Schmitz H; Frang D
    Int Urol Nephrol; 1993; 25(6):565-9. PubMed ID: 7513678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sabal serrulata extract (Strogen forte) in the treatment of symptomatic benign prostatic hyperplasia.
    Kondás J; Philipp V; Diószeghy G
    Int Urol Nephrol; 1996; 28(6):767-72. PubMed ID: 9089044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Benign prostatic hyperplasia--treatment with sabal fruit extract. A treatment study of 1,334 patients].
    Vahlensieck W; Völp A; Lubos W; Kuntze M
    Fortschr Med; 1993 Jun; 111(18):323-6. PubMed ID: 7689525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [An urodynamic study of patients with benign prostatic hypertrophy treated conservatively with phytotherapy or testosterone (author's transl)].
    Flamm J; Kiesswetter H; Englisch M
    Wien Klin Wochenschr; 1979 Sep; 91(18):622-7. PubMed ID: 90434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of benign prostatic hyperplasia. Results of a treatment study with the phytogenic combination of Sabal extract WS 1473 and Urtica extract WS 1031 in urologic specialty practices].
    Schneider HJ; Honold E; Masuhr T
    Fortschr Med; 1995 Jan; 113(3):37-40. PubMed ID: 7534258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Saw palmetto. Serenoa repens. Also known as Serenoa serrulata, Sabal serrulata and the dwarf palm.
    Barnes J
    J Prim Health Care; 2009 Dec; 1(4):323. PubMed ID: 20690343
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical evaluation of Cernilton in benign prostatic hypertrophy].
    Hayashi J; Mitsui H; Yamakawa G; Suga A; Kai A; Shimabukuro T; Yanagi K; Fujisawa S; Takihara H; Kaneda Y
    Hinyokika Kiyo; 1986 Jan; 32(1):135-41. PubMed ID: 2421560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Results of a double-blind study on the effectiveness of ERU (extractum radicis Urticae) capsules in conservative treatment of benign prostatic hyperplasia].
    Vontobel HP; Herzog R; Rutishauser G; Kres H
    Urologe A; 1985 Jan; 24(1):49-51. PubMed ID: 2580383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical study of Eviprostat for the treatment of benign prostatic hyperplasia].
    Song Y; Li NC; Wang XF; Ma LL; Wan B; Hong BF; Na YQ
    Zhonghua Nan Ke Xue; 2005 Sep; 11(9):674-6. PubMed ID: 16209208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prostaplant treatment of benign prostatic hyperplasia].
    Medvedev AA; Siniakova LA; Zaĭtsev AV
    Urologiia; 2000; (4):13-5. PubMed ID: 11186685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the sabal serrulata extract IDS 89 and its subfractions on 5 alpha-reductase activity in human benign prostatic hyperplasia.
    Weisser H; Tunn S; Behnke B; Krieg M
    Prostate; 1996 May; 28(5):300-6. PubMed ID: 8610056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined extracts of Urtica dioica and Pygeum africanum in the treatment of benign prostatic hyperplasia: double-blind comparison of two doses.
    Krzeski T; Kazón M; Borkowski A; Witeska A; Kuczera J
    Clin Ther; 1993; 15(6):1011-20. PubMed ID: 7509261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Conservative treatment of benign prostatic hypertrophy: reevaluation of the effect of eviprostat by subjective symptoms and uroflowmetry].
    Matsuura T; Wakabayashi A; Kaneko S; Kurita T
    Hinyokika Kiyo; 1986 Jun; 32(6):903-6. PubMed ID: 2429533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relief by botulinum toxin of lower urinary tract symptoms owing to benign prostatic hyperplasia: early and long-term results.
    Brisinda G; Cadeddu F; Vanella S; Mazzeo P; Marniga G; Maria G
    Urology; 2009 Jan; 73(1):90-4. PubMed ID: 18995889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of voiding position on uroflowmetric parameters and post-void residual urine volume in patients with benign prostatic hyperplasia.
    Unsal A; Cimentepe E
    Scand J Urol Nephrol; 2004; 38(3):240-2. PubMed ID: 15204379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical effects of allylestrenol on patients with benign prostatic hyperplasia (BPH) evaluated with criteria for treatment efficacy in BPH].
    Noguchi K; Takeda M; Hosaka M; Kubota Y
    Hinyokika Kiyo; 2002 May; 48(5):269-73. PubMed ID: 12094708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzyme activities in tissue of human benign prostatic hyperplasia after three months' treatment with the Sabal serrulata extract IDS 89 (Strogen) or placebo.
    Weisser H; Behnke B; Helpap B; Bach D; Krieg M
    Eur Urol; 1997; 31(1):97-101. PubMed ID: 9032543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role of intravesical capsaicin instillation in benign prostatic hyperplasia with overactive bladder symptoms: the first reported study in the literature.
    Mahawong P; Chaiyaprasithi B; Soontrapa S; Tappayuthapijarn P
    J Med Assoc Thai; 2007 Nov; 90(11):2301-9. PubMed ID: 18181311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of benign prostatic hyperplasia with phytosterols.
    Carbin BE; Larsson B; Lindahl O
    Br J Urol; 1990 Dec; 66(6):639-41. PubMed ID: 1702340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.